RaySearch Laboratories AB (publ) - Asset Resilience Ratio

Latest as of September 2025: 16.60%

RaySearch Laboratories AB (publ) (RAY-B) has an Asset Resilience Ratio of 16.60% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read RaySearch Laboratories AB (publ) balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Skr322.80 Million
≈ $34.74 Million USD Cash + Short-term Investments

Total Assets

Skr1.94 Billion
≈ $209.24 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2003–2024)

This chart shows how RaySearch Laboratories AB (publ)'s Asset Resilience Ratio has changed over time. See shareholders equity of RaySearch Laboratories AB (publ) for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down RaySearch Laboratories AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of RaySearch Laboratories AB (publ).

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr322.80 Million 16.6%
Short-term Investments Skr0.00 0%
Total Liquid Assets Skr322.80 Million 16.60%

Asset Resilience Insights

  • Good Liquidity Position: RaySearch Laboratories AB (publ) maintains a healthy 16.60% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

RaySearch Laboratories AB (publ) Industry Peers by Asset Resilience Ratio

Compare RaySearch Laboratories AB (publ)'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Longmaster Information Tech
SHE:300288
Health Information Services 0.68%
Echoiq Ltd
AU:EIQ
Health Information Services 11.12%
ARTRYA Ltd
AU:AYA
Health Information Services 48.49%
Pharmx Technologies Ltd
AU:PHX
Health Information Services 22.16%
Intelicare Holdings Ltd
AU:ICR
Health Information Services 64.05%
Global Health Ltd
AU:GLH
Health Information Services 9.84%
Pro Medicus Ltd
AU:PME
Health Information Services 54.64%
Cogstate Ltd
AU:CGS
Health Information Services 54.90%

Annual Asset Resilience Ratio for RaySearch Laboratories AB (publ) (2003–2024)

The table below shows the annual Asset Resilience Ratio data for RaySearch Laboratories AB (publ).

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 22.13% Skr462.74 Million
≈ $49.80 Million
Skr2.09 Billion
≈ $225.04 Million
+4.53pp
2023-12-31 17.60% Skr343.68 Million
≈ $36.99 Million
Skr1.95 Billion
≈ $210.14 Million
+9.06pp
2022-12-31 8.54% Skr160.27 Million
≈ $17.25 Million
Skr1.88 Billion
≈ $201.88 Million
+2.65pp
2021-12-31 5.90% Skr102.53 Million
≈ $11.03 Million
Skr1.74 Billion
≈ $187.15 Million
-7.24pp
2020-12-31 13.13% Skr168.75 Million
≈ $18.16 Million
Skr1.28 Billion
≈ $138.28 Million
+4.13pp
2019-12-31 9.01% Skr113.86 Million
≈ $12.25 Million
Skr1.26 Billion
≈ $136.05 Million
+0.49pp
2004-12-31 8.51% Skr3.87 Million
≈ $416.15K
Skr45.42 Million
≈ $4.89 Million
-8.65pp
2003-12-31 17.17% Skr5.28 Million
≈ $568.21K
Skr30.76 Million
≈ $3.31 Million
--
pp = percentage points

About RaySearch Laboratories AB (publ)

ST:RAY-B Sweden Health Information Services
Market Cap
$625.45 Million
Skr5.81 Billion SEK
Market Cap Rank
#11392 Global
#178 in Sweden
Share Price
Skr188.70
Change (1 day)
+3.80%
52-Week Range
Skr168.40 - Skr365.50
All Time High
Skr365.50
About

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a tre… Read more